| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201807C Quick acting external ointment for treating injury and gall and preparing method thereof |
| 05/18/2005 | CN1201800C Medicinal liquor for curing traumatic injury and rhematalgia and preparing method thereof |
| 05/18/2005 | CN1201798C Medicine for stopping pain and strengthening bone |
| 05/18/2005 | CN1201791C External plaster for treating rheumatic arthralgia and its preparing method |
| 05/18/2005 | CN1201781C Medicine compositions for treating head-ache, and its prepn. method |
| 05/18/2005 | CN1201773C Wind dispelling oil and producing process |
| 05/18/2005 | CN1201764C Chinese medicine oil preparation for promoting blood circulation |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894061 Substituted dihydrophenanthridinesulfonamides |
| 05/17/2005 | US6894046 For treating eosinophil-dependent inflammatory diseases, asthma |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6894033 Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 05/17/2005 | US6894028 Use of KPV tripeptide for dermatological disorders |
| 05/17/2005 | US6893838 DADD, death activator death domain protein |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 05/17/2005 | US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies |
| 05/17/2005 | US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/17/2005 | CA2335492C Pyrrolo[2,3-d]pyrimidine compounds |
| 05/17/2005 | CA2306782C Isoquinolines as urokinase inhibitors |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2005042507A1 Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt |
| 05/12/2005 | WO2005042027A2 Antagonists of the bradykinin b1 receptor |
| 05/12/2005 | WO2005041858A2 Mucin production inhibitor |
| 05/12/2005 | WO2005016514A3 Combinatorial synthesis on support |
| 05/12/2005 | WO2005002572A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 05/12/2005 | WO2004073628A3 Novel compounds |
| 05/12/2005 | WO2004071391A3 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 05/12/2005 | WO2004039358A8 Adhesive composition for dermal patch and production process thereof |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | US20050101781 Eponemycin and epoxomicin analogs and uses thereof |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging |
| 05/12/2005 | US20050101662 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; cancer, Alzheimer's disease, gout, atherosclerosis, restenosis |
| 05/12/2005 | US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101636 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 05/12/2005 | US20050101634 Bis(5-aeyl-2-pyridyl) derivatives |
| 05/12/2005 | US20050101632 Treating inflammation of the skin or mucous membrane by topical administration of an anti-inflammatory amount of dimethicone in the absence of any other anti-inflammatory agent |
| 05/12/2005 | US20050101628 Useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101591 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 05/12/2005 | US20050101584 Selective estrogen receptor-beta ligands |
| 05/12/2005 | US20050101575 Vitamin d3 derivatives and remedies using the same |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101536 Modulation of angiogenesis |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/12/2005 | US20050100617 Method for improving age-related physiological deficits and increasing longevity |
| 05/12/2005 | US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response |
| 05/12/2005 | US20050100547 Also a method for detecting an agent capable of binding TRAF2 binding site of sphingosine kinase by contacting cells with a putative agent and detecting an altered expression phenotype |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | DE10197266T5 Verfahren zur örtlichen Betäubung und Schmerzstillung Method for local anesthesia and pain relief |
| 05/12/2005 | CA2545499A1 Antagonists of the bradykinin b1 receptor |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543649A1 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 05/12/2005 | CA2543530A1 Use of biocompatible polymers for the preparation of a composition or a medical device |
| 05/12/2005 | CA2543438A1 Improved aza-bridged-bicyclic amino acid derivatives as a4 integrin antagonists |
| 05/12/2005 | CA2542837A1 The use of non-opiates for the potentiation of opiates |
| 05/12/2005 | CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1529053A2 Macrolide compounds endowed with antiinflammatory activity |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529045A2 New compounds |
| 05/11/2005 | EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/11/2005 | EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 05/11/2005 | EP1528909A1 Trihydroxy polyunsaturated eicosanoids |
| 05/11/2005 | EP1399127B1 Olopatadine formulations for topical administration |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/11/2005 | EP1059930B1 Compositions comprising isovaleramide and ibuprofen |
| 05/11/2005 | CN2698344Y Medical pain easing plaster |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615302A Positive-working photoimageable bottom antireflective coating |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615146A 生姜提取物制剂 Ginger extract preparation |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1615135A Oral dosage form of a sulfonamide prodrug such as parecoxib |
| 05/11/2005 | CN1613874A Human tumour necrosin antibody, its preparation and medicinal composition |
| 05/11/2005 | CN1613498A Chinese medicine oral liquid for treating rheumatism |